Notice of Results and Investor Presentation
Futura Medical PLC will release its interim results for the six months ended June 30, 2025, on Tuesday, September 30, 2025. Management will host a webinar via the Investor Meet Company platform on September 30, 2025, at 09.30am BST to discuss the results. The presentation is open to all existing and potential shareholders, who can submit questions in advance until 9.00am BST the day before or during the live presentation. Interested parties can register for the presentation through a provided link.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Futura Medical plc (AIM: FUM), the consumer healthcare company behind Eroxon, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, will release its interim results for the six months ended 30 June 2025 on Tuesday 30 September.
Management will be hosting a webinar relating to the results via the Investor Meet Company platform on 30 September 2025, at 09.30am BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9.00am BST the day before, or at any time during the live presentation.
Investors can register for the presentation via the following link: https://www.investormeetcompany.com/futura-medical-plc/register-investor. Investors who already follow Futura on the Investor Meet Company platform will automatically be invited.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.